AzTrials
AzTrials

ShoulderNCT01544244

The Global Shoulder Concept (GSC) Method Versus Classic Physical Therapy for Shoulder Tendinitis

A study testing GSC physical therapy and Standard physical therapy in people with Shoulder and Tendinopathy, run by Centre Hospitalier Universitaire de Nīmes at 2 sites in France.

Terminated

Stopped early. The study ended before it was planned to and will not resume.

Official record
Search all trials

Trial summary

The primary objective of this study is to demonstrate the superiority of the CGE physical therapy protocol versus a standard physical therapy protocol of the shoulder by measuring the following after 1 month of physical therapy: the FI2S score including validated measures of pain, glenohumeral joint range of motion in… Read more about this study

Who is it for?
Ages 18 to 70 years
Conditions the study is for
Shoulder, Tendinopathy
What is being tested?
GSC physical therapy and Standard physical therapy
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
40 participants
Where
2 sitesFrance
Study dates
Oct 2012to May 2016
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 70 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • The patient must have given his/her informed and signed consent
  • The patient must be insured or beneficiary of a health insurance plan
  • painful, chronic tendinopathy (more than 3 months) of the rotator cuff, confirmed by MRI

Who cannot join

  • The patient is pregnant or breastfeeding
  • Any emergency situation
  • Non-mechanical tendinopathies (metabolic, neurological, capsulitis, reflex sympathetic dystrophy) and tendon surgery (tendon surgery and acromioplasty)

Trial locations and contacts

2 sites in 1 country.

France2 sites
  • CHU de Montpellier - Hôpital Lapeyronie

    Montpellier, 34295

  • CHU de Nîmes - Hôpital Universitaire Carémeau

    Nîmes, 30029

Other trials in France

About this study

Official title: Comparison of the Global Shoulder Concept (GSC) Method Versus Classic Physical Therapy for Shoulder Tendinitis: a Prospective, Randomized Study

The primary objective of this study is to demonstrate the superiority of the CGE physical therapy protocol versus a standard physical therapy protocol of the shoulder by measuring the following after 1 month of physical therapy: the FI2S score including validated measures of pain, glenohumeral joint range of motion in the three planes, the ability to perform certain everyday activities and the strength of forward elevation measured with a dynamometer.

Read the detailed description

Secondary objectives:

  • To study the evolution of passive glenohumeral range of motion
  • To study the evolution of the global range of passive and active motion for each method used
  • To evaluate functional recovery (DASH)
  • To evaluate the impact on quality of life (SF36)
  • To study the difference in visual analog scale scores for pain during physical therapy sessions
  • Compare the two methods/groups after three months.
Being tested
GSC physical therapy, Standard physical therapy
Keywords
comparison of physical therapy strategies
Medical subject headings
Tendinopathy

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • GSC physical therapyProcedure or surgery

    Global Shoulder Concept physical therapy sequence for shoulder tendonitis. The procedures used in this protocol refer to physical therapy sequences, not to devices or drugs.

  • Standard physical therapyProcedure or surgery

    Standard physical therapy sequence for shoulder tendonitis. The procedures used in this protocol refer to physical therapy sequences, not to devices or drugs.

Study groups in NCT01544244
Study groupRoleWhat they receive
GSC physcial therapyExperimentalPatients included in this arm of the study will follow the Global Shoulder Concept physical therapy sequence.
Receives: Procedure: GSC physical therapy
StandardActive comparatorPatients in this arm of the study will follow the standard physical therapy sequence.
Receives: Procedure: Standard physical therapy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. change in FI2S score

    Measured: 90 days

Secondary outcomes (23)
  1. Change in visual analog scale for pain

    Measured: Day 1 versus baseline

  2. Change in visual analog scale for pain

    Measured: Day 5 versus baseline

  3. Change in visual analog scale for pain

    Measured: Day 12 versus baseline

  4. Change in visual analog scale for pain

    Measured: Day 19 versus baseline

  5. Change in visual analog scale for pain

    Measured: Day 26 versus baseline

  6. Change in visual analog scale for pain

    Measured: Day 90 versus baseline

  7. Scapulohumeral amplitude gain in 3 main directions

    Passive and active mobility are evaluated by manual goniometry.

    Measured: Day 1

  8. Scapulohumeral amplitude gain in 3 main directions

    Passive and active mobility are evaluated by manual goniometry.

    Measured: Day 26

  9. Scapulohumeral amplitude gain in 3 main directions

    Passive and active mobility are evaluated by manual goniometry.

    Measured: Day 90

  10. Functional gain as measured by the DASH self questionnaire

    Measured: Day 1

  11. Functional gain as measured by the DASH self questionnaire

    Measured: Day 5

  12. Functional gain as measured by the DASH self questionnaire

    Measured: Day 12

  13. Functional gain as measured by the DASH self questionnaire

    Measured: Day 19

  14. Functional gain as measured by the DASH self questionnaire

    Measured: Day 26

  15. Functional gain as measured by the DASH self questionnaire

    Measured: Day 90

  16. FI2S score

    Measured: Day 1

  17. FI2S score

    Measured: Day 5

  18. FI2S score

    Measured: Day 12

  19. FI2S score

    Measured: Day 19

  20. FI2S score

    Measured: Day 26

  21. SF36 self questionnaire

    Measured: Day 1

  22. SF36 self questionnaire

    Measured: Day 26

  23. SF36 self questionnaire

    Measured: Day 90

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Mar 2012 (estimated)
  2. Study startOct 2012
  3. Primary completionMay 2016
  4. Study completionMay 2016

Why it stopped: Inclusion curve too slow.

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
40 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01544244
Sponsor's protocol ID
PHRIP/2011/DR-03
Other IDs
2011-A01168-33
Status last verified
Jun 2016
First submitted
23 Feb 2012
Last updated
3 Jun 2016
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A study testing GSC physical therapy and Standard physical therapy in people with Shoulder and Tendinopathy, run by Centre Hospitalier Universitaire de Nīmes at 2 sites in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: stopped early, as of the sponsor's last update on 3 Jun 2016. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was stopped early (reason given: Inclusion curve too slow.). Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

change in FI2S score (time frame: 90 days). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Jun 2016.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in